A detailed history of Coastal Investment Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Coastal Investment Advisors, Inc. holds 1,114 shares of LLY stock, worth $875,860. This represents 0.47% of its overall portfolio holdings.

Number of Shares
1,114
Previous 4,298 74.08%
Holding current value
$875,860
Previous $3.89 Million 74.66%
% of portfolio
0.47%
Previous 0.77%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$772.14 - $960.02 $2.46 Million - $3.06 Million
-3,184 Reduced 74.08%
1,114 $986,000
Q2 2024

Jul 15, 2024

BUY
$724.87 - $909.04 $90,608 - $113,630
125 Added 3.0%
4,298 $3.89 Million
Q1 2024

Apr 19, 2024

BUY
$592.2 - $792.28 $76,986 - $102,996
130 Added 3.22%
4,173 $3.25 Million
Q4 2023

Jan 19, 2024

SELL
$525.19 - $619.13 $235,285 - $277,370
-448 Reduced 9.98%
4,043 $2.36 Million
Q3 2023

Oct 20, 2023

SELL
$434.7 - $599.3 $47,817 - $65,923
-110 Reduced 2.39%
4,491 $2.41 Million
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $93,998 - $125,686
268 Added 6.19%
4,601 $2.16 Million
Q1 2023

May 05, 2023

SELL
$310.63 - $364.82 $82,006 - $96,312
-264 Reduced 5.74%
4,333 $1.49 Million
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $93,249 - $108,654
-290 Reduced 5.93%
4,597 $1.68 Million
Q3 2022

Oct 27, 2022

BUY
$296.48 - $337.87 $230,661 - $262,862
778 Added 18.93%
4,887 $1.58 Million
Q2 2022

Aug 09, 2022

SELL
$278.73 - $327.27 $4,738 - $5,563
-17 Reduced 0.41%
4,109 $1.33 Million
Q1 2022

Apr 13, 2022

SELL
$234.69 - $291.66 $19,244 - $23,916
-82 Reduced 1.95%
4,126 $1.18 Million
Q4 2021

Jan 18, 2022

BUY
$224.85 - $279.04 $3,597 - $4,464
16 Added 0.38%
4,208 $1.16 Million
Q3 2021

Oct 18, 2021

BUY
$221.6 - $272.71 $15,068 - $18,544
68 Added 1.65%
4,192 $969,000
Q2 2021

Jul 15, 2021

SELL
$180.55 - $233.54 $2,527 - $3,269
-14 Reduced 0.34%
4,124 $947,000
Q1 2021

Apr 12, 2021

BUY
$164.32 - $212.72 $239,578 - $310,145
1,458 Added 54.4%
4,138 $773,000
Q4 2020

Jan 13, 2021

SELL
$130.46 - $172.63 $1,565 - $2,071
-12 Reduced 0.45%
2,680 $452,000
Q3 2020

Oct 23, 2020

BUY
$146.22 - $169.13 $88,901 - $102,831
608 Added 29.17%
2,692 $398,000
Q2 2020

Jul 16, 2020

BUY
$136.42 - $164.18 $284,299 - $342,151
2,084 New
2,084 $342,000
Q1 2020

Apr 23, 2020

SELL
$119.05 - $147.35 $227,385 - $281,438
-1,910 Closed
0 $0
Q4 2019

Feb 05, 2020

SELL
$106.92 - $132.43 $3,421 - $4,237
-32 Reduced 1.65%
1,910 $223,000
Q3 2019

Oct 18, 2019

SELL
$106.79 - $116.16 $18,901 - $20,560
-177 Reduced 8.35%
1,942 $216,000
Q2 2019

Aug 01, 2019

BUY
$110.79 - $129.32 $83,535 - $97,507
754 Added 55.24%
2,119 $235,000
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $151,938 - $178,842
1,365 New
1,365 $177,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $747B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Coastal Investment Advisors, Inc. Portfolio

Follow Coastal Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.